1. Home
  2. MDAI vs PDSB Comparison

MDAI vs PDSB Comparison

Compare MDAI & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAI
  • PDSB
  • Stock Information
  • Founded
  • MDAI 2013
  • PDSB 2005
  • Country
  • MDAI United States
  • PDSB United States
  • Employees
  • MDAI N/A
  • PDSB N/A
  • Industry
  • MDAI Medical/Dental Instruments
  • PDSB Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDAI Health Care
  • PDSB Health Care
  • Exchange
  • MDAI Nasdaq
  • PDSB Nasdaq
  • Market Cap
  • MDAI 51.9M
  • PDSB 44.5M
  • IPO Year
  • MDAI N/A
  • PDSB N/A
  • Fundamental
  • Price
  • MDAI $2.13
  • PDSB $0.94
  • Analyst Decision
  • MDAI Strong Buy
  • PDSB Strong Buy
  • Analyst Count
  • MDAI 1
  • PDSB 2
  • Target Price
  • MDAI $3.50
  • PDSB $10.00
  • AVG Volume (30 Days)
  • MDAI 868.8K
  • PDSB 855.7K
  • Earning Date
  • MDAI 11-11-2025
  • PDSB 11-14-2025
  • Dividend Yield
  • MDAI N/A
  • PDSB N/A
  • EPS Growth
  • MDAI N/A
  • PDSB N/A
  • EPS
  • MDAI N/A
  • PDSB N/A
  • Revenue
  • MDAI $27,549,000.00
  • PDSB N/A
  • Revenue This Year
  • MDAI N/A
  • PDSB N/A
  • Revenue Next Year
  • MDAI $60.05
  • PDSB N/A
  • P/E Ratio
  • MDAI N/A
  • PDSB N/A
  • Revenue Growth
  • MDAI 22.27
  • PDSB N/A
  • 52 Week Low
  • MDAI $1.01
  • PDSB $0.85
  • 52 Week High
  • MDAI $3.25
  • PDSB $3.41
  • Technical
  • Relative Strength Index (RSI)
  • MDAI 44.61
  • PDSB 42.88
  • Support Level
  • MDAI $2.07
  • PDSB $0.91
  • Resistance Level
  • MDAI $2.27
  • PDSB $1.16
  • Average True Range (ATR)
  • MDAI 0.19
  • PDSB 0.08
  • MACD
  • MDAI -0.04
  • PDSB 0.01
  • Stochastic Oscillator
  • MDAI 7.61
  • PDSB 16.70

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: